Gain-of-function (GoF) mutations in PIEZO1 cause dehydrated hereditary stomatocytosis (DHS) or hereditary xerocytosis, an autosomal dominant hemolytic anemia characterized by high reticulocyte count, a tendency to macrocytosis, and mild jaundice, as well as by other variably penetrant clinical features, such as perinatal edema, severe thromboembolic complications after splenectomy, and hepatic iron overload. PIEZO1 mutations in DHS lead to slowing inactivation kinetics of the ion channel and/or facilitating channel opening in response to physiological stimuli. To characterize the alterations of red blood cell proteome in PIEZO1 mutated patients, we used a differential approach to compare the proteome of DHS patients (16 patients from 13 unrelated pedigrees) versus healthy subjects. We identified new actors in the regulation of the complex landscape of ion and volume balance of erythrocytes mediated by PIEZO1. Particularly, the main impaired processes in DHS patients were: ion homeostasis, transmembrane transport, regulation of vesicle-mediated transport, and the proteasomal catabolic process. Functional assays demonstrated a co-expression of PIEZO1 and Band3 when PIEZO1 was activated. Moreover, the alteration of the vesicle-mediated transport was functionally demonstrated by the increased vesiculation rate in DHS patients compared to healthy controls. This finding provides also an explanation of the pathogenetic mechanism underlying the increased thrombotic rate observed in these patients. Finally, the newly identified proteins, involved in the intracellular signaling pathways altered by PIEZO1 mutations, could be used in the future as potential druggable targets in DHS.